These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2503016)
41. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue. Donskov F; Basse PH; Hokland M Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263 [TBL] [Abstract][Full Text] [Related]
42. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
43. Induction of cytotoxic cell activities by a novel cyclic disulfide compound, SA3443 in vivo. Sasano M; Tanaka M; Nakata K; Mita S Immunopharmacol Immunotoxicol; 1991; 13(1-2):121-33. PubMed ID: 1770215 [TBL] [Abstract][Full Text] [Related]
44. Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithine. Susskind BM; Sekar J; Tandon PM; Lind DS; Bear HD Cell Immunol; 1991 Mar; 133(1):41-54. PubMed ID: 1899361 [TBL] [Abstract][Full Text] [Related]
45. Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytes. Kawai H; Komiyama A; Katoh M; Yabuhara A; Miyagawa Y; Akabane T Transfusion; 1988; 28(6):531-5. PubMed ID: 3264091 [TBL] [Abstract][Full Text] [Related]
48. Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor. Nagarkatti M; Nagarkatti PS; Kaplan AM Cancer Immunol Immunother; 1988; 27(1):38-46. PubMed ID: 3260820 [TBL] [Abstract][Full Text] [Related]
49. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance. Dean JH; Ward EC; Murray MJ; Lauer LD; House RV; Stillman W; Hamilton TA; Adams DO Int J Immunopharmacol; 1986; 8(2):189-98. PubMed ID: 3086244 [TBL] [Abstract][Full Text] [Related]
50. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Mulé JJ; Schwarz SL; Roberts AB; Sporn MB; Rosenberg SA Cancer Immunol Immunother; 1988; 26(2):95-100. PubMed ID: 2452015 [TBL] [Abstract][Full Text] [Related]
51. The differential inhibitory effects exerted by cyclosporine and hydrocortisone on the activation of human cytotoxic lymphocytes by recombinant interleukin-2 versus allospecific CTL. Grimm EA; Muul LM; Wilson DJ Transplantation; 1985 May; 39(5):537-40. PubMed ID: 3158107 [TBL] [Abstract][Full Text] [Related]
52. Immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC 45662). Weir MR; Li XW; Gomolka D; Peppler R; O'Bryan-Tear G; Moran M Transplant Proc; 1991 Feb; 23(1 Pt 2):1074-7. PubMed ID: 1989152 [No Abstract] [Full Text] [Related]
53. In vivo and in vitro effect of Cantastim, an immunomodulatory agent extracted from a highly pathogenic Pseudomonas aeruginosa strain. Olinescu A; Hristescu S; Sålågeanu A; Manda G; Neagu M Neoplasma; 1991; 38(1):119-28. PubMed ID: 1901383 [TBL] [Abstract][Full Text] [Related]
54. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells. Kerr PG; Atkins RC Immunol Cell Biol; 1991 Jun; 69 ( Pt 3)():177-83. PubMed ID: 1835710 [TBL] [Abstract][Full Text] [Related]
55. Organophosphorus pesticides markedly inhibit the activities of natural killer, cytotoxic T lymphocyte and lymphokine-activated killer: a proposed inhibiting mechanism via granzyme inhibition. Li Q; Nagahara N; Takahashi H; Takeda K; Okumura K; Minami M Toxicology; 2002 Apr; 172(3):181-90. PubMed ID: 11893417 [TBL] [Abstract][Full Text] [Related]
56. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Purasiri P; Mckechnie A; Heys SD; Eremin O Immunology; 1997 Oct; 92(2):166-72. PubMed ID: 9415022 [TBL] [Abstract][Full Text] [Related]
57. Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. Kawakami Y; Klein TW; Newton C; Djeu JY; Specter S; Friedman H Int J Immunopharmacol; 1988; 10(4):485-8. PubMed ID: 2844686 [TBL] [Abstract][Full Text] [Related]
58. The role of L-alanyl-L-glutamine in the immune response in vitro. Kircher B; Eibl G; Enrich B; Lätzer K; Herold M; Niederwieser D Wien Klin Wochenschr; 2002 Aug; 114(15-16):702-8. PubMed ID: 12602115 [TBL] [Abstract][Full Text] [Related]
59. Target cell-induced inactivation of cytolytic lymphocytes. Role and regulation of CD45 and calyculin A-inhibited phosphatase in response to interleukin-2. Bajpai A; Brahmi Z J Biol Chem; 1994 Jul; 269(29):18864-9. PubMed ID: 8034641 [TBL] [Abstract][Full Text] [Related]
60. 2'-2'-difluorodeoxycytidine: in vitro effects on cell-mediated immune response. Alvino E; Fuggetta MP; Tricarico M; Bonmassar E Anticancer Res; 1998; 18(5A):3597-602. PubMed ID: 9858945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]